We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Tool Detects Early Warning Signs of Breast Cancer

By LabMedica International staff writers
Posted on 10 Oct 2025

Branching is a vital biological process that enables organs like the lungs, kidneys, and breasts to perform complex functions. More...

In female mammary glands, most branching occurs after birth—during puberty and pregnancy—when milk ducts expand to prepare for breastfeeding. Disturbances in this process are closely linked to breast cancer risk. However, studying mammary gland branching is difficult and time-consuming, as traditional methods require slicing tissue and manually counting ducts under a microscope. Now, scientists have developed a new analytical tool that quantifies mammary gland branching quickly and accurately. The tool could be used to study how hormonal changes and treatments affect mammary glands or even to detect early warning signs of breast cancer.

Researchers at Cold Spring Harbor Laboratory (CSHL, Cold Spring Harbor, NY, USA) created the Mammary Gland Network analysis tool, or MaGNet, to study the structure of mouse mammary glands. The system applies principles of network theory to biological imaging, translating the complex architecture of milk ducts into quantifiable data points. Using MaGNet, researchers can measure the total length of ductal trees, the number of ducts and alveoli, and the degree of branching in stained images of breast tissue. The process is supported by NetworkX software, which plots the structures as interconnected networks for computational analysis.

The idea for MaGNet was inspired by a mathematical model originally applied to plants, which was adapted to analyze mammary gland branching patterns. In practice, users trace the ducts in digital tissue images and use computer code to calculate network parameters. The tool eliminates inconsistencies caused by manual analysis and allows scientists to visualize the entire ductal architecture at once. The study describing this method was published in the Journal of Mammary Gland Biology and Neoplasia.

Currently, MaGNet has been tested in mice, but its flexible design means it can be modified for other branching systems. The tool’s developers anticipate that it could be used to investigate how hormones, infections, or life stages—such as pregnancy and menopause—affect mammary gland development and cancer risk. In addition to basic research, MaGNet could support early disease detection by identifying subtle architectural changes in breast tissue before tumors become visible through imaging or physical examination.

The technology represents an important step toward improving breast health monitoring through quantitative, data-driven methods. With further development, MaGNet may contribute to understanding how branching abnormalities signal early cancer development, ultimately advancing diagnostic capabilities and preventative strategies in oncology.

“We’re always hunting for warning signs that arise before you can feel a lump or see anything on a mammogram or ultrasound,” said Steven Lewis, a graduate researcher in the Dos Santos Lab at Cold Spring Harbor Laboratory. “Imagine an automated tool could say there’s no tumor yet, but there are changes detectable. That’s our hope, our dream.”

Related Links:
CSHL


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Sudhaunsh Deshpande holding the molecularly imprinted polymer-based biosensor (Photo courtesy of University of Liverpool)

AI-Powered Blood Tests Enable Early Detection of Alzheimer’s Disease

Alzheimer’s disease, the most common form of dementia, affects more than 55 million people globally. Early diagnosis is critical for managing symptoms and slowing progression, yet current testing methods... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.